Your session is about to expire
← Back to Search
Tofacitinib for Juvenile Arthritis
Study Summary
This trial will evaluate the long-term safety and tolerability of tofacitinib in patients with juvenile idiopathic arthritis (JIA) who have previously participated in tofacitinib JIA studies.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 3 trial • 209 Patients • NCT02281552Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a long-term infection.I am under 18, have JIA, and need tofacitinib as per my doctor's advice.I am infected with HIV, hepatitis B, or hepatitis C.You have had an infected joint replacement in the past and still have the replacement in place.I have stopped taking certain medications as required and only take approved ones.I have long-lasting arthritis in few joints and a type of juvenile arthritis.You had an infection that required treatment within the two weeks leading up to the start of the study.I haven't had a serious infection or been hospitalized for an infection in the last 3 months.I have had shingles more than once or a widespread herpes simplex infection.I have completed a study for JIA treatment with tofacitinib, without stopping early due to serious side effects.
- Group 1: Tofacitinib
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Will this research project be studying people who are over the age of 50?
"Out of the total 419 clinical trials, this is one of the 63 that specifically looks at patients below 18 years old. To be eligible for enrollment in this trial, children must be between 2 to 18 years old."
Do you know of any other research that has been conducted on Tofacitinib?
"At this time, there are a total of 7 Phase 3 trials and 34 clinical studies underway that are investigating tofacitinib. The majority of these medical investigations are based in Shanghai, but tofacitinib's clinical trials can be found at 656 locations worldwide."
What are the main conditions that Tofacitinib has been shown to be effective for?
"Tofacitinib is a medication that has been used to treat juvenile arthritis. It can also be given to patients who are intolerant or unresponsive to methotrexate therapy."
When was Tofacitinib cleared by the FDA?
"Tofacitinib has been given a safety score of 3. This is because it is currently in Phase 3 clinical trials, which suggests that while there is data supporting its efficacy, there are also multiple rounds of data confirming its safety."
How many people with the condition being studied may join this clinical trial?
"In order to collect the desired data, this study requires 340 willing participants that meet the set inclusion criteria. Currently, there are two locations where patients can be enrolled: Johns Hopkins All Children's Hospital in Saint Pertersburg, Florida and Phoenix Children's Hospital in Phoenix, Arizona."
Are there several facilities conducting this experiment in town?
"Johns Hopkins All Children's Hospital in Saint Petersburg, Florida, Phoenix Children's Hospital in Phoenix, Arizona and All Children's Hospital Speciality Physicians in Saint Petersburg are the main locations for this study. However, there are also 22 other sites where aspects of the trial are taking place."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger